版本:
中国

BRIEF-Immunovaccine presents preclinical research on novel monoclonal antibodies

April 5 Immunovaccine Inc-

* Immunovaccine Inc presents preclinical research at aacr 2017 on ability of novel monoclonal antibodies to boost efficacy of depovax(tm)-based cancer immunotherapy

* Immunovaccine-Data demonstrated phosphatidylserine targeting antibodies can enhance anti-cancer activity of depovax-based therapeutic vaccine platform

* Immunovaccine Inc - data suggests that antibody targeting ps can increase anti-tumor immune response induced by a depovax-based cancer immunotherapy Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐